Literature DB >> 32930458

Regulatory CD4+ and CD8+ T cells are negatively correlated with CD4+ /CD8+ T cell ratios in patients acutely infected with SARS-CoV-2.

Menglu Gao1, Yili Liu1, Mingquan Guo1, Qianying Wang1, Yan Wang1, Jian Fan1, Yinzhong Shen1, Junjie Hou2, Yanmin Wan3,4, Zhaoqin Zhu1.   

Abstract

Regulatory T cell can protect against severe forms of coronaviral infections attributable to host inflammatory responses. But its role in the pathogenesis of COVID-19 is still unclear. In this study, frequencies of total and multiple subsets of lymphocytes in peripheral blood of COVID-19 patients and discharged individuals were analyzed using a multicolor flow cytometry assay. Plasma concentration of IL-10 was measured using a microsphere-based immunoassay kit. Comparing to healthy controls, the frequencies of total lymphocytes and T cells decreased significantly in both acutely infected COVID-19 patients and discharged individuals. The frequencies of total lymphocytes correlated negatively with the frequencies of CD3- CD56+ NK cells. The frequencies of regulatory CD8+ CD25+ T cells correlated with CD4+ /CD8+ T cell ratios positively, while the frequencies of regulatory CD4+ CD25+ CD127- T cells correlated negatively with CD4+ /CD8+ T cell ratios. Ratios of CD4+ /CD8+ T cells increased significantly in patients beyond age of 45 years. And accordingly, the frequencies of regulatory CD8+ CD25+ T cells were also found significantly increased in these patients. Collectively, the results suggest that regulatory CD4+ and CD8+ T cells may play distinct roles in the pathogenesis of COVID-19. Moreover, the data indicate that NK cells might contribute to the COVID-19 associated lymphopenia. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  CD4+ T cell; CD8+ T cell; COVID-19; lymphopenia; regulatory T cell

Year:  2020        PMID: 32930458     DOI: 10.1002/JLB.5COVA0720-421RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease-a report from a highly complex hospital in Brazil.

Authors:  Douglas Câmara de Oliveira; Beatriz Sanada Spiri; Yara Carolina Schluga; Julie Lilian Pimentel Justus; Francisco Diego Negrão Lopes Neto; Ana Paula de Azambuja
Journal:  Hematol Transfus Cell Ther       Date:  2022-06-29

Review 2.  Role of hormones in the pregnancy and sex-specific outcomes to infections with respiratory viruses.

Authors:  Orlando Cervantes; Irene Cruz Talavera; Emma Every; Brahm Coler; Miranda Li; Amanda Li; Hanning Li; Kristina Adams Waldorf
Journal:  Immunol Rev       Date:  2022-04-04       Impact factor: 10.983

3.  T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Amal F Alshammary; Jawaher M Alsughayyir; Khalid K Alharbi; Abdulrahman M Al-Sulaiman; Haifa F Alshammary; Heba F Alshammary
Journal:  Front Med (Lausanne)       Date:  2022-04-28

Review 4.  The T cell immune response against SARS-CoV-2.

Authors:  Paul Moss
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

5.  Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study.

Authors:  Xue-Song Wen; Dan Jiang; Lei Gao; Jian-Zhong Zhou; Jun Xiao; Xiao-Cheng Cheng; Bin He; Yue Chen; Peng Lei; Xiao-Wei Tan; Shu Qin; Dong-Ying Zhang
Journal:  BMC Infect Dis       Date:  2021-01-12       Impact factor: 3.090

6.  Efficacy of Low-Temperature Plasma-Assisted Unilateral/Bilateral Tonsillectomy and Adenoidectomy in Children with Obstructive Sleep Apnea Hypopnea Syndrome.

Authors:  Yi Qiao; Jie Chen
Journal:  Med Sci Monit       Date:  2021-09-09

Review 7.  Multiple Sclerosis, COVID-19 and Vaccines: Making the Point.

Authors:  Simona Toscano; Clara G Chisari; Francesco Patti
Journal:  Neurol Ther       Date:  2021-10-08

Review 8.  CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

9.  Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.

Authors:  Igor V Kudryavtsev; Natalia A Arsentieva; Zoia R Korobova; Dmitry V Isakov; Artem A Rubinstein; Oleg K Batsunov; Irina V Khamitova; Raisa N Kuznetsova; Tikhon V Savin; Tatiana V Akisheva; Oksana V Stanevich; Aleksandra A Lebedeva; Evgeny A Vorobyov; Snejana V Vorobyova; Alexander N Kulikov; Maria A Sharapova; Dmitrii E Pevtsov; Areg A Totolian
Journal:  Viruses       Date:  2022-08-28       Impact factor: 5.818

10.  The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials.

Authors:  Robert L Murphy; Eustache Paramithiotis; Scott Sugden; Todd Chermak; Bruce Lambert; Damien Montamat-Sicotte; John Mattison; Steve Steinhubl
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.